Out-Licensing of Finished Products
Home > Finished Products
High-Quality Generics & Global Reach
We specialize in delivering finished pharmaceutical products that meet international standards. Our portfolio covers oncology, immuno-oncology, and rare diseases, ensuring innovative and accessible treatments for patients worldwide.
Available Products
We help you compete in the fastest growing therapeutic categories with high-quality generics.
| Product | Category | Reference | Dosage | Strength | CTD |
|---|---|---|---|---|---|
| Bosutinib | Oncology | Bosulif® | Tablets | 100 mg | Available |
| Dasatinib | Oncology | Sprycel® | Tablets | 20 / 70 mg | Available |
| Letrozole | Oncology | Femara® | Tablets | 2.5 mg | Available |
| Sorafenib | Oncology | Nexavar® | Tablets | 200 mg | Available |
| Sunitinib | Oncology | Sutent® | Capsules | 12.5/25/50/75 mg | Available |
Why Choose Us?
Quality Assured
EU-GMP compliant facilities with strict quality checks.
Global Presence
Trusted by partners and clients across multiple continents.
Sustainable
Committed to eco-friendly practices in all processes.
Dedicated Support
Expert assistance for licensing and technical queries.
Pipeline & Co-development
We provide opportunities in oncology, immuno-oncology and rare diseases with world-class licensing and co-development.
| Product | Category | Reference | Dosage | Strength | CTD |
|---|---|---|---|---|---|
| Lenvatinib | Oncology | Lenvima® | Capsules | 4/10 mg | Under development |
| Rucaparib | Oncology | Rubraca® | Tablets | 50/100/250 mg | Under development |
| Cabozantinib | Oncology | Cabometyx® | Tablets | 20/40/60 mg | Under development |
Certifications & Approvals
EU-GMP
Certified for manufacturing and packaging of potent molecules.
SFDA & ANVISA
Approved by Saudi and Brazilian regulatory authorities.
Turkish MOH
Recognized compliance with Turkish Ministry of Health standards.
Subscribe to Our Newsletter
Stay updated with our latest launches and offers.
What Our Clients Say
"Excellent service and professional team!"
Gareth Smith
System Analyst
Frequently Asked Questions
What therapeutic areas do you focus on?
We primarily focus on oncology, immuno-oncology and rare diseases.
Are your products internationally compliant?
Yes, our facilities are EU-GMP compliant and approved by several international authorities.
How can I partner with you?
You can reach out via our contact form for licensing and co-development opportunities.
Partner With Us Today
Explore licensing and co-development opportunities to bring high-quality medicines to patients worldwide.